Table 2.
Relative risk* associated or not with MDR-AB infection in patients affected or not by COVID-19
| Variables | RR | CI 95% | p value |
|---|---|---|---|
| Previous hospitalization (90 days) | 0.4 | 0.2–0.9 | 0.031 |
| COPD | 0.3 | 0.1–0.9 | 0.029 |
| Chronic steroid therapy | 0.1 | 0.0–0.9 | 0.041 |
| Infection at time of ICU admission | 0.1 | 0.0–0.4 | 0.001 |
| Serum lactate levels > 2 mmol/l | 1.8 | 1.3–2.5 | 0.001 |
| Acinetobacter baumannii colonization | 7.9 | 4.0–15.7 | < 0.001 |
| Bloodstream infection | 6.5 | 3.2–13.3 | < 0.001 |
| Steroid therapy | 18.4 | 7.6–44.1 | < 0.001 |
RR relative risk, CI confidence interval, COPD chronic obstructive pulmonary disease, ICU intensive care unit
*RR < 1 is associated with non-COVID-19 etiology; > 1 with COVID-19